328 filings
10-K
2023 FY
FENC
Fennec Pharmaceuticals Inc
Annual report
29 Mar 24
4:14pm
8-K
FENC
Fennec Pharmaceuticals Inc
25 Mar 24
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
4:05pm
8-K
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
424B7
FENC
Fennec Pharmaceuticals Inc
15 Mar 24
Prospectus with selling stockholder info
3:53pm
8-K/A
FENC
Fennec Pharmaceuticals Inc
6 Mar 24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
4:07pm
8-K
tjlj7nvj6i87pzsn04z
29 Feb 24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
4:04pm
8-K
b8csfz8mqumhdcwrdjym
2 Feb 24
FDA Issues Reminder of Non-Substitution of PEDMARKÒ (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
12:00am
EFFECT
3b9m27x
18 Dec 23
Notice of effectiveness
12:15am
CORRESP
25tob7gpc6c37
13 Dec 23
Correspondence with SEC
12:00am
8-K
wac2n 46g
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
UPLOAD
va4wualt7 xrm
28 Nov 23
Letter from SEC
12:00am
8-K
dufh5btkmw4txfm dvo
6 Nov 23
Fennec Pharmaceuticals Announces Third Quarter 2023
7:38pm
8-K/A
rcb72lcr
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
5jz5s21ejebqi
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
394e8gmr ejsi
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am
8-K
oofk4j9dbt5k
12 Jun 23
Submission of Matters to a Vote of Security Holders
6:24pm
8-K
k7x18n0x8d0a1p
6 Jun 23
Other Events
5:39pm